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Abstract 26 
 27 
Ageing is associated with a dysfunctional endothelial phenotype, as well as reduced 28 
angiogenic capabilities. Exercise exerts beneficial effects on the cardiovascular 29 
system, possibly by increasing/maintaining the number and/or function of circulating 30 
angiogenic cells (CACs) that are known to decline with age. However, the 31 
relationship between cardiorespiratory fitness (CRF) and age related changes in 32 
frequency of CACs, as well as the exercise-induced responsiveness of CACs in older 33 
individuals has not yet been determined. One hundred and seven healthy male 34 
volunteers, aged 18-75 years, participated in the study 1. CRF was estimated using 35 
submaximal cycling ergometer test. Circulating endothelial progenitor cells (EPCs), 36 
angiogenic T-cells (TANG) and their CXCR4 cell surface receptor expression were 37 
enumerated by flow cytometry using peripheral blood samples obtained under resting 38 
conditions prior to the exercise test. Study 2 recruited 17 healthy males (8 young, 18-39 
25 yrs; 9 older, 60-75yrs) and these participants undertook a 30-minute cycling 40 
exercise bout at 70% ?̇?O2max, with CACs enumerated pre- and immediately post-41 
exercise. Age was inversely associated with both CD34
+
 progenitor cells (r
2
=-0.140, 42 
p=0.000) and TANG (r
2
=-0.176, p=0.000) cells, as well as CXCR4-expressing CACs 43 
(CD34
+
, r
2
=-0.167, p=0.000; EPCs: r
2
=-0.098, p=0.001; TANG, r
2
=-0.053, p=0.015). 44 
However, after correcting for age, CRF had no relationship with either CAC subset. In 45 
addition, older individuals displayed attenuated exercise-induced increases in CD34
+
 46 
progenitor cells, TANG, CD4
+ 
TANG, and CD8
+
CXCR4
+
 TANG cells. Older men display 47 
lower CAC levels, which may contribute to increased CVD risk, and older adults 48 
display an impaired exercise-induced responsiveness of these cells. 49 
 50 
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New and Noteworthy: 51 
Older adults display lower circulating progenitor cell and angiogenic T-cell counts 52 
compared to younger individuals, independent of cardiometabolic risk factors and 53 
cardiorespiratory fitness. 54 
Older adults also display impaired exercise-induced mobilization of these 55 
vasculogenic cells. 56 
 57 
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Introduction 61 
 62 
Cardiovascular disease (CVD) has been estimated to contribute to nearly 30% of all 63 
deaths worldwide (22). Risk factors include smoking, hypertension, dyslipidemia, 64 
diabetes, physical inactivity and ageing (8, 21). As a result of medical advancements, 65 
the death rate from CVD has fallen in comparison to the 1970s (22); however, as a 66 
population we are becoming older and are living longer. Therefore age is becoming a 67 
more significant risk factor for developing CVD. 68 
 69 
Endothelial dysfunction is an important step in the development of CVD. Endothelial 70 
function is impaired in those with CVD compared to healthy controls (11) with 71 
increased oxidative stress purported to be a possible mechanism, through reducing 72 
nitric oxide bioavailability (38). Advancing age is often characterized with a 73 
dysfunctional endothelium (4), leading us to believe that the age-related decline in 74 
 4 
endothelial function may be an important mechanism in the age-related increase in 75 
CVD risk. 76 
 77 
Circulating angiogenic cells (CACs) play a role in the maintenance of a healthy 78 
endothelium. CACs include endothelial progenitor cells (EPCs; CD34
+
, 79 
CD34
+
CD45
dim
VEGFR2
+
), which can promote endothelial regeneration and 80 
maintenance of endothelial function through replacing damaged or dysfunctional 81 
endothelial cells, or by secreting proangiogenic factors which support the proliferation 82 
of resident endothelial cells (16). These cells are also independent predictors of 83 
endothelial function (6) and have been demonstrated to be reduced in the circulation 84 
or have impaired function in those with CVD or those with risk factors for CVD 85 
compared to healthy controls (17, 41). There have been observations that circulating 86 
EPC counts are lower in older vs younger individuals (39) and that progenitor cell 87 
function is impaired with age (44). Therefore, maintaining high levels of EPCs later in 88 
life may offer protection against the onset and/or progression of CVD by helping to 89 
maintain a healthy endothelium. 90 
 91 
Recently, a new subset of CACs, CD3
+
 T-cells that co-express CD31, have been 92 
identified (15). These T-cells were found to be required for optimal in vitro growth of 93 
EPCs (15) and have been termed ‘angiogenic T-cells’, or TANG. TANG are able to 94 
secrete significantly higher levels of proangiogenic factors (e.g. VEGF, IL-8 and G-95 
CSF) than their CD31
-
 counterparts (15). These TANG cells are inversely correlated 96 
with Framingham Risk Score (FRS), as well as age (15, 20) and are also reduced in 97 
those with cerebral small vessel disease (34), indicating that the reduction of these T-98 
cells may play a role in onset of CVD.  99 
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 100 
Exercise and physical activity have been consistently shown to be protective against 101 
CVD (14, 25). The observed risk reduction may be due, in part, to the improved 102 
endothelial function observed with exercise training and increased levels of physical 103 
activity (4). Acute (33, 40), and chronic exercise training (43) have been shown to 104 
lead to increased circulating number and/or function of EPCs in humans, as well as 105 
some recent data from our lab showing large increases in circulating TANG cells in 106 
response to acute exercise (32). However, there is no research to date to show the 107 
effects of age on the acute exercise response of both CAC populations, and thus this 108 
warrants investigation. 109 
 110 
Both CAC subsets reportedly express C-X-C chemokine receptor 4 (CXCR4) (15, 111 
32), which is involved in cell migration and neovascularization capacity of EPCs (42). 112 
Blocking of CXCR4 on such cells results in reduced ability of EPCs to migrate to 113 
both SDF-1α and VEGF in vitro via disrupted intracellular signalling between 114 
CXCR4 and downstream target, Janus Kinase 2 (42), which suggests CXCR4 115 
expression on CACs may confer functional benefits. CXCR4
+
 bone marrow-derived 116 
cells have been shown to be lower in aged animal models (45), however data in 117 
humans are lacking. We have shown that a single bout of exercise preferentially 118 
mobilized CXCR4-expressing TANG cells in healthy young males (32), but there is no 119 
study to date investigating age-related differences in exercise-induced mobilization of 120 
CXCR4
+
 CACs. 121 
 122 
The aim of study 1 was to investigate the effects of age on both EPCs and TANG 123 
populations and the cell surface receptor expression of C-X-C chemokine receptor 4 124 
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(CXCR4), which is involved in regulation of migration of CACs (42, 43), in addition 125 
to the effects of cardiorespiratory fitness (CRF) on these cell populations in a cross-126 
sectional study in healthy men aged 18-75yrs. The aim of study 2 was to investigate 127 
the effects of an acute bout of exercise on mobilization of CACs in young and older 128 
men (18-25yrs, and 60-75yrs). It was hypothesized that age would be negatively 129 
associated with both CAC subsets, and that CRF would be positively associated with 130 
CAC subsets independent of age. It was also hypothesized that older individuals will 131 
display an attenuated exercise-induced increase in CAC populations in comparison vs. 132 
younger individuals. 133 
 134 
Materials and Methods 135 
 136 
Study 1 137 
 138 
Subjects 139 
 140 
One hundred and seven healthy, non-obese (body mass index [BMI] <30), non-141 
smoking, male participants aged 18-75yrs (Table 1), were recruited to the cross-142 
sectional study. The study was approved by Edinburgh Napier University’s Research 143 
Ethics and Governance Committee. All subjects gave written informed consent prior 144 
to data collection. 145 
 146 
Subjects reported to the Human Performance Laboratory after an overnight fast, 147 
having not exercised for at least 24 hours prior to the visit, having refrained from 148 
alcohol consumption the night before and having not ingested caffeine the morning of 149 
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the visit. Subjects were measured for height, body mass (from this BMI was 150 
calculated) and waist and hip circumference measures were taken to calculate waist-151 
to-hip ratio. Blood pressure (BP) was measured using an automated BP cuff after 5-152 
minute supine rest. 153 
 154 
Blood Sampling 155 
 156 
Venepuncture was performed with the subjects in a supine position after 5-minutes 157 
rest. A 21-gauge needle and collection kit (BD Biosciences, USA) was used for 158 
collection of peripheral blood samples. Blood samples were evacuated into 6ml tubes 159 
spray-coated with Ethylene Diamine Tetraacetic Acid (EDTA) anticoagulants using 160 
the BD Vacutainer Safety-Lok
TM
 system (BD Biosciences, USA). In addition, 6ml 161 
serum tubes (BD Biosciences) were used for the collection of blood for quantification 162 
of cardiovascular risk factors (fasting glucose, triglycerides, LDL-cholesterol and 163 
HDL-cholesterol). Peripheral blood in EDTA vacutainers were also centrifuged at 164 
1500g x 15 minutes at 22°C, and subsequent plasma aliquoted for analysis of 165 
associated mobilizing factors. Plasma was frozen at -80°C until analysis. 166 
 167 
Peripheral Blood Mononuclear Cell Separation 168 
 169 
Mononuclear cells (MNC) were isolated using density gradient centrifugation using 170 
Lymphoprep
TM
 (Axis-Shield plc, United Kingdom), as previously described (32)  171 
 172 
Flow Cytometric Quantification of CD31
+
 T-Cells 173 
 174 
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Briefly, 0.5 x 10
6
 MNCs were incubated with 1L anti-CD3-APC, anti-CD31-FITC 175 
and anti-CXCR4-PE-Cy5 (BD Biosciences, USA) for 45 minutes at 4˚C in the dark. 176 
Immediately prior to flow cytometric enumeration, 500µL PBS-BSA was added. 177 
TANG cells and CXCR4 cell surface expression were quantified on a flow cytometer 178 
(BD FACS Calibur, BD Biosciences, USA). Lymphocyte gate was identified using a 179 
forward scatter and side-scatter plot. A minimum of 100,000 lymphocyte events were 180 
collected per sample. Isotypes for both CD31 (FITC Anti-Mouse Isotype; BD 181 
Biosciences, USA) and CXCR4 (PE-Cy5 Anti-Mouse Isotype; BD Biosciences, USA) 182 
were used in matched concentrations as controls to distinguish between positive and 183 
negative events. Following data acquisition, data was analyzed using FCS Express 184 
v3.0 (De Novo, Los Angeles, USA). The percentage of all lymphocytes and 185 
lymphocyte subsets expressing CD3, CD31 and CXCR4 were analyzed, and total 186 
TANG cells were calculated by multiplying the percentage of lymphocytes expressing 187 
the cell surface antigens of interest by total lymphocyte count as quantified by semi-188 
automated haematology analyser (XS-1000i, Sysmex, Japan). All flow cytometry T-189 
cell data were measured in duplicate and averaged. 190 
 191 
Flow Cytometric Quantification of Endothelial Progenitor Cells 192 
 193 
EPCs were quantified using peripheral whole blood using a BD FACS Calibur (BD 194 
Biosciences, USA). Briefly, 200L of EDTA whole blood was incubated with 10L 195 
of Fc Receptor Blocking Reagent (Miltenyi Biotec, Germany) for 15 minutes in the 196 
dark at 4C, followed by incubation with 10L anti-CD34-FITC, 10L anti-CD45-197 
APC, 15L anti-VEGFR2-PE and 10L anti-CXCR4-PE-Cy5 (all BD Biosciences 198 
USA) for 45 minutes at 4C in the dark. Samples containing no antibody for VEGFR2 199 
 9 
and CXCR4 were used as negative controls. Subsequently, 2mL Pharm Lyse
TM
 (BD 200 
Biosciences, USA) was added and left to incubate for 20 minutes prior to flow 201 
cytometric quantification of the EPCs. For each sample, 500,000 CD45
+
 events were 202 
collected for analysis. Flow cytometric data for EPCs was analyzed using FCS 203 
Express v3.0 (De Novo, Los Angeles, USA), and expressed as % MNCs.  204 
 205 
Gating strategies for both TANG and EPCs are shown in Figure 1. 206 
 207 
Analysis of Circulating SDF-1α, Lipids, Cholesterol and Fasting Glucose 208 
 209 
Aliquots of plasma (peripheral blood centrifuged at 1500g x 15 minutes) and platelet-210 
free plasma (PFP; double centrifugation at 1500g x 15 minutes followed by 211 
centrifugation at 13000g x 2 minutes) were prepared and stored -80˚C. Circulating 212 
SDF-1α was analyzed by enzyme-linked immunosorbent assay (ELISA) in PFP 213 
(R&D Systems Inc., USA). Fasting glucose, triglycerides, total cholesterol (TC), 214 
high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol 215 
(LDL-C) were measured in human serum by semi-automated spectrophotometry (RX 216 
Monza Clinical Chemistry Analyzer, Randox, UK). All samples were measured in 217 
duplicates and average values used for analysis. 218 
 219 
Submaximal Exercise Test Protocol for Estimation of Maximal Oxygen Consumption 220 
(?̇?O2max) 221 
 222 
All participants completed a submaximal cycling exercise test (YMCA) as described 223 
by Golding et al. (12), to estimate maximal oxygen uptake (?̇?O2max). The YMCA 224 
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submaximal cycling test consisted of 3-4 x 3 minute incremental stages, starting at 225 
50W at 50rpm. The exercise test was completed when the participants reached their 226 
predicted 80% maximum heart rate. Heart rate was measured continuously throughout 227 
the test (Polar, Finland). Using HR and ?̇?O2 values measured using breath-by-breath 228 
gas analysis (MasterScreen
TM
 CPX, Jaeger
®
, CareFusion, USA), ?̇? O2max was 229 
estimated using the equations provided by Adams and Beam (1) . 230 
 231 
Study 2 232 
 233 
Subjects 234 
 235 
Eight young (18-25yrs) and nine older (60-75yrs) physically active, healthy males 236 
took part in the second study. Subject characteristics for study 2 are shown in Table 2. 237 
The study was approved by Edinburgh Napier University’s Research Ethics and 238 
Governance Committee. All subjects gave written informed consent prior to data 239 
collection. 240 
 241 
Subjects were required to attend the Human Performance Laboratory on 2 occasions. 242 
The first visit was used to ascertain subjects’ ?̇?O2max, from which the workload at 243 
70% ?̇?O2max was calculated for use for the 2
nd
 visit (30-minute cycling bout). 244 
 245 
Visit 1 246 
  247 
Subjects reported to the Human Performance Laboratory after an overnight fast, 248 
having not exercised for at least 24 hours prior to each visit, having refrained from 249 
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alcohol consumption the night before and having not ingested caffeine the morning of 250 
the visit. Subjects were measured for height, and body mass (from this BMI was 251 
calculated). Blood pressure (BP) was measured using an automated BP cuff after 5-252 
minute supine rest. 253 
 254 
Subjects underwent a graded cycling exercise test to volitional exhaustion. Breath-by-255 
breath measures were made to quantify ?̇?O2max. Heart rate (Polar, Finland) and 256 
rating of perceived exhaustion (RPE) (5) was monitored throughout the test. 257 
Regression analyses were performed to calculate workload at 70% ?̇?O2max. 258 
 259 
Visit 2 260 
 261 
After an overnight fast, participants undertook a 30 minute cycling ergometer bout at 262 
70% ?̇?O2max, with blood samples taken pre- and immediately post-exercise. Blood 263 
samples were used for the quantification of circulating EPCs (33) and TANG cells by 264 
flow cytometry as previously described (32). Both cell populations were expressed as 265 
absolute counts (cells·ml
-1
 or cells·µl
-1
 using % of gated events against differential 266 
leukocyte count). Blood was also processed for plasma for quantification of 267 
circulating mobilizing factors (VEGF, granulocyte colony stimulating factor [G-CSF], 268 
SDF-1α) by enzyme-linked immunosorbent assay (ELISA).  269 
 270 
Statistical Analysis 271 
 272 
All data were assessed for normal distribution. Progenitor cell data were not normally 273 
distributed and so were logarithmically or square root transformed. CD34
+
 cell subset 274 
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comparisons between age groups (18-30yrs, 31-50yrs, and 51-75yrs) for study 1 were 275 
performed on non-transformed data using Kruskal-Wallis rank comparisons tests with 276 
Dunn’s test for multiple comparisons, and TANG comparisons between age groups 277 
performed using one-way analysis of variance (ANOVA), with Bonferroni post-hoc 278 
tests performed to correct for multiple comparisons. To assess the influence of age 279 
and CRF and other circulating factors on CAC number and CXCR4 cell surface 280 
expression (Study 1, % CACs expressing CXCR4 and mean fluorescence intensity 281 
[MFI]), single linear regressions were performed using Pearson’s coefficient (R2) and 282 
F-statistics. Subsequent multiple linear regressions were performed to control for the 283 
influence of age and cardiometabolic risk factors on CACs to investigate if CRF had 284 
any independent effect on circulating number of EPCs and or TANG cells. In all 285 
models, standardized regression coefficients (Beta-values) and R
2
 values are reported 286 
as measures of association between variables and cell subsets.  287 
 288 
To analyse the influence of an acute  bout of exercise on CAC levels in both young 289 
and older men (Study 2), mixed model ANOVA analyses were performed, with age 290 
group as the independent factor, and time (pre, immediately post-exercise) as fixed 291 
factor. To adjust for multiple comparisons, Bonferroni post-hoc tests were performed. 292 
Pearson correlations were performed to assess the relationship between changes in 293 
CACs and known chemoattractants for these cells. Independent T-tests were 294 
performed to determine significant differences between age groups in baseline 295 
characteristics and trial data. 296 
 297 
Data was analyzed using SPSS for Windows (IBM, USA) and GraphPad Prism 7 for 298 
Windows (GraphPad Software, Inc, USA). Significance was set at alpha (p) ≤0.05. 299 
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Data are presented as mean ± standard error of the mean (SEM) unless otherwise 300 
stated.  301 
 302 
Results 303 
 304 
Chronological Age and Circulating Angiogenic Cells 305 
 306 
Circulating CD34
+
CD45
dim
 cells were significantly lower in the 51-75yrs group 307 
compared to the 18-30yrs group (0.106 ± 0.010% vs. 0.143 ± 0.011%, p<0.01), and 308 
lower in the 31-50yrs group compared to the 18-30yrs group (0.113 ± 0.009% vs. 309 
0.143 ± 0.011%, p<0.05). Circulating EPCs (CD34
+
CD45
dim
VEGFR2
+
) only 310 
significantly differed between the 18-30yrs and 31-50yrs group (0.015 ± 0.006% vs. 311 
0.004 ± 0.001%, p<0.001). There was a trend for a difference for circulating EPCs 312 
between 18-30yrs and 51-70yrs (0.015 ± 0.006% vs. 0.009 ± 0.001%), but this 313 
difference was not significant. There were significant differences observed for 314 
CXCR4
+
 HPCs between 51-75yrs compared to 18-30yrs (0.040 ± 0.006% vs. 0.089 ± 315 
0.009, p<0.005) and 31-50yrs compared with 18-30yrs (0.048 ± 0.006% vs. 0.089 ± 316 
0.009%, p<0.005), but no significant differences between 31-50yrs and 51-75yrs in 317 
CXCR4
+
 HPC count. CXCR4-positive EPCs were only significantly different 318 
between 18-30yrs and 31-50yrs (0.011 ± 0.002% vs. 0.004 ± 0.001%, p<0.001), with 319 
no other significant differences found, despite a trend for lower circulating cells in 51-320 
75yrs compared to 18-30yrs group (0.006 ± 0.001% vs. 0.011 ± 0.002%). Circulating 321 
TANG cells were significantly lower in the 51-75yrs group compared to the 18-30yrs 322 
(539 ± 32 cells.μl-1 vs. 751 ± 42 cells.μl-1, respectively, p<0.001). In addition, TANG 323 
cells were lower in the 31-50yrs group compared to the 18-30yrs group (631 ±34 324 
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cells.μl-1 vs. 751 ± 42 cells.μl-1, p<0.05). There was no significant difference in TANG 325 
cells between 31-50yrs and 51-75yrs groups. There were no significant differences in 326 
these age groups for CXCR4
+
 TANG cell number. CAC differences between age groups 327 
are shown in Figure 2. 328 
 329 
Advancing age was associated with a lower number of circulating CD34
+
 progenitor 330 
cells (r= -0.374, r
2
=0.140, p=0.000) as well as a significantly lower number of 331 
circulating TANG cells (CD3
+
CD31
+
 cells·µL
-1
: r = -0.420, r
2 
= 0.176, p = 0.000; % of 332 
total CD3
+
 cells: r = -0.510, r
2 
= 0.260, p = 0.000). Additionally, the number of 333 
circulating CXCR4-expressing CD34
+
 progenitors, and CXCR4-expressing EPCs 334 
(CD34
+
CD45
dim
VEGFR2
+
) were also inversely related to chronological age 335 
(CD34
+
CXCR4
+
: r = -0.408, r
2 
= 0.167, p = 0.000; CXCR4
+
 EPCs: r = -0.313, r
2 
= 336 
0.098, p = 0.001), however total circulating EPCs was not found to be significantly 337 
associated with chronological age (r = -0.153, r
2 
= 0.023, p = 0.058). CXCR4-338 
expressing TANG cells were inversely associated with age (r = -0.230, r
2 
= 0.053, p = 339 
0.008). CXCR4 cell surface expression intensity, as quantified as mean fluorescence 340 
intensity (MFI) of CXCR4-expressing EPCs was significantly lower with advancing 341 
age (r = -0.177, r
2 
= 0.031, p = 0.036), but no such observation was made for 342 
CXCR4
+
 CD34 progenitor cells, or CXCR4-expressing TANG cells. Data is shown in 343 
Supplementary Tables 1, 2 and 3. 344 
 345 
Influence of Cardiorespiratory Fitness on the Age-Associated Decline in Circulating 346 
Angiogenic Cells 347 
 348 
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To assess the potential for CRF to attenuate the advancing age associated lower 349 
number in CAC numbers, submaximal exercise tests were performed to quantify 350 
CRF, and estimated ?̇?O2max was used as a marker of CRF. These values in study 1 351 
ranged from 16.89ml·kg·min
-1
 to 66.78ml·kg·min
-1
. Stepwise multiple regression 352 
analyses were performed to assess the influence of CRF on CAC subsets after 353 
correcting for age. After including age in the predictive model, there was no impact of 354 
CRF on the basal levels of these CACs or CXCR4-expressing CACs (Supplementary 355 
Table 1: CD34
+
 progenitors; Supplementary Table 2: EPCs, Supplementary Table 3: 356 
TANG cells), with age remaining a significant independent predictor of resting 357 
CD34
+
/CD34
+
CXCR4
+
CXCR4
+
 EPCs/TANG/CXCR4
+
 TANG cells in males aged 18-75 358 
years.  359 
 360 
Influence of Cardiometabolic Risk Factors and Circulating Angiogenic Cell 361 
Mobilizing Factors on EPCs and TANG Cells 362 
 363 
The association of other cardiometabolic risk factors, such as BMI, blood pressure, 364 
waist-to-hip ratio, fasting glucose, and lipid profile (LDL-C, HDL-C, total 365 
cholesterol), as well as SDF-1α, a known mobilizing factor for progenitor cells, with 366 
these various CACs were quantified using several multiple level regression analyses 367 
after correcting for age. Of note, after controlling for age, systolic pressure was 368 
positively associated with TANG cells (r
2
-change = 0.038, F-change = 5.205, p = 369 
0.024) and CXCR4
+
 TANG cells (r
2
-change = 0.036, F-change = 4.232, p = 0.042). 370 
Total cholesterol was positively associated with CXCR4 cell surface expression on 371 
CD34
+
 progenitor cells (CXCR4 MFI, r
2
-change = 0.133, F-change = 15.010, p = 372 
0.000), but inversely associated with percentage of TANG cells expressing CXCR4 (r
2
-373 
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change=0.066, F change=6.918, p=0.010), and CXCR4 expression intensity on TANG 374 
cells (r
2
-change = 0.051, F-change = 5.331, p = 0.023). In addition, LDL-C was 375 
positively associated with CXCR4 MFI on CD34
+
 progenitors (r
2
-change = 0.112, F-376 
change = 12.389, p = 0.001), but negatively associated with circulating CXCR4
+ 
TANG 377 
cells (r
2
-change = 0.044, F-change = 4.614, p = 0.034), and intensity of CXCR4 378 
expression on TANG cells (r
2
-change = 0.058, F-change = 6.165, p = 0.015). 379 
 380 
After controlling for age, SDF-1α was positively associated with the circulating 381 
number of CXCR4-expressing CD34
+
 progenitors (r
2
-change = 0.038, F-change = 382 
4.489, p = 0.029), but conversely was negatively associated with CXCR4 MFI on 383 
these CD34
+
 cells (r
2
-change = 0.056, F-change = 6.308, p = 0.014). 384 
 385 
Due to the potential confounding factors systolic blood pressure (TANG, CXCR4
+
 386 
TANG), total cholesterol (CD34
+
CXCR4
+
 MFI, CXCR4-expressing TANG, TANG 387 
CXCR4 MFI), LDL-C (CD34
+
CXCR4
+
 MFI, CXCR4
+
 TANG, TANG CXCR4 MFI) and 388 
SDF-1α (CXCR4-expressing CD34+ cells, CD34+CXCR4+ MFI), these were again 389 
entered into the regression analyses to assess the CRF on these CAC variables after 390 
controlling for age and these cardiometabolic and mobilizing factors. After 391 
controlling for age and these factors, CRF had no association with any of the given 392 
CAC variables (data not shown). 393 
 394 
Acute Exercise and EPC Mobilization: Influence of Age 395 
 396 
There was a main effect of exercise on circulating CD34
+
CD45
dim
 (p = 0.018, F (1, 397 
16) = 6.998) and CD34
+
CD45
dim
VEGFR2
+ 
progenitor cells (p = 0.003, F (1, 16) = 398 
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11.99). There was no main effect of exercise on CXCR4-expressing progenitor cells. 399 
There was a significant exercise x age interaction for both CD34
+
CD45
dim 
400 
haematopoietic progenitors (p = 0.019, F (1, 16) = 6.869) and a close to significant 401 
interaction for CD34
+
CD45
dim
VEGFR2
+
 EPCs (p = 0.098, F (1, 16) = 3.123). This 402 
was reflected by significantly greater absolute cell mobilization in younger vs. older 403 
individuals for both CD34
+
CD45
dim
 haematopoietic progenitors (1140 ± 294 404 
cells·mL
-1
 vs. 275 ± 191 cells·mL
-1
, respectively, p = 0.029) and a trend for increased 405 
EPC mobilization in young vs. older adults (212 ± 72 cells·mL
-1 
vs. 67 ± 23 cells·mL
-
406 
1
, respectively, p = 0.076). There were no such exercise x age interactions, or 407 
differences between age groups for absolute cell mobilization for CXCR4-expressing 408 
progenitors. Progenitor cell data is shown in Figure 3. 409 
 410 
Acute Exercise and TANG Changes: Influence of Age 411 
 412 
Due to insufficient blood draw in one young participant, analysis includes 8 young, 413 
and nine older individuals. The single bout of moderate intensity exercise 414 
significantly elevated total TANG cells (CD3
+
CD31
+
: p=0.001, F (1, 14) = 18.47), 415 
CD4
+
 TANG (p = 0.011, F (1, 14) = 8.65) and CD8
+
 TANG cells (p = 0.007, F (1, 14) = 416 
10.25). There was a significant exercise x age interaction for total TANG cells 417 
(p=0.029, F (1, 14) = 6.07) with younger individuals displaying greater response, but 418 
not for either CD4
+ 
(p=0.058, F (1, 14) = 4.34) or CD8
+
 TANG cells (p = 0.148, F (1, 419 
14) = 2.37). 420 
 421 
CXCR4-expressing TANG cells and CD4
+
 TANG cells did not significantly change with 422 
exercise in either group (p>0.05), but there was significant exercise and interaction 423 
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effects for CD8
+
CXCR4
+
 TANG cells (main effect of exercise: p = 0.019, F (1, 14) = 424 
7.06; interaction exercise x age: p = 0.040, F (1, 14) = 5.11) with the younger 425 
individuals demonstrating a greater response to the exercise bout. Independent T-test 426 
analysis revealed significantly greater absolute cell changes in young individuals 427 
compared to older men for TANG (634 ± 173 cells·μl
-1
 vs. 262 ± 77 cells·μl-1, p = 428 
0.046), CD4
+ 
TANG (229 ± 84 cells·μl
-1
 vs. 59 ± 19 cells·μl-1, p = 0.027), and CXCR4-429 
expressing CD8
+
 TANG cells  (88 ± 35 cells·μl
-1
 vs. 11 ± 6 cells·μl-1, p = 0.039). Data 430 
for TANG cell changes with age and exercise are shown in Figure 4. 431 
 432 
Acute Exercise and CAC Mobilizing Factors 433 
 434 
Exercise resulted in an increase in circulating plasma VEGF and cortisol (main effects 435 
of exercise: p = 0.012, p= 0.000, respectively). There was a significant exercise x age 436 
interaction for cortisol (p = 0.006, F (1, 15) = 10.366) but not for VEGF (p = 0.220, F 437 
(1, 15) = 1.659; Figure 5). To investigate if there is a relationship between increases 438 
in circulating VEGF, G-CSF, SDF-1α and cortisol with changes in CACs, several 439 
Pearson correlations were performed. There were no relationships evident for changes 440 
in G-CSF and cortisol for any CAC subset changes with exercise, but significant 441 
positive relationships were found for changes in SDF-1α and CD34+CD45dim (r = 442 
0.898,  p = 0.015) progenitor cell changes with exercise, but only for the young 443 
individuals. Interestingly, when analysing age groups in isolation, changes in cortisol 444 
were significantly associated with changes in total TANG cells (r = 0.715, p = 0.030). 445 
 446 
Discussion 447 
 448 
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The main findings of the two studies were that older age was characterized by a lower 449 
number of a variety of CACs in healthy men aged 18-75 years, and CRF was 450 
unsuccessful in attenuating this effect. In addition, older adults display an impaired 451 
mobilization of CD34
+
 progenitor cells and ingress of TANG cells into circulation in 452 
comparison to younger individuals. 453 
 454 
Advancing age was shown to be significantly deleterious for a CD34
+
 progenitors, 455 
and CD31
+
 T-cells, named angiogenic T-cells (TANG). These CACs play an important 456 
role in the maintenance of endothelial function (6, 18) and the associated advancing 457 
age-associated lower numbers of these cells as shown in this study and others (20, 39) 458 
may represent a key mechanism in the ageing decline in endothelial function (4) and 459 
endothelial repair ability (43). This decline in endothelial function is a key process in 460 
the development of atherosclerotic CVD. Our study is also the first study to state that 461 
CXCR4-expressing CACs are also significantly lower in circulating number with age. 462 
CXCR4 expression on these cells may play an important role in the migratory ability 463 
of these cells (15, 42, 43), and thus the loss of CXCR4 expression on CACs may play 464 
a role in CAC dysfunction, potentially subsequently leading to development of 465 
endothelial dysfunction. Kushner et al. (20) found that CAC migration to SDF-1α, a 466 
CAC chemokine bound by CXCR4, was associated more strongly to endothelial 467 
function than TANG cell number alone. Interestingly, Xia et al. (44) observed no 468 
differences in CXCR4-expressing CACs or intracellular CXCR4 content in EPCs 469 
between age groups, but rather found an impaired CXCR4:JAK-2 intracellular 470 
signalling under stimulation with SDF-1α in the older compared to the younger men. 471 
The differences between our study and the study by Xia et al. (44) can be explained 472 
by methodological differences, as we measured cell surface CXCR4 expression on 473 
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CACs by flow cytometry, whereas Xia et al. (44) quantified total cell CXCR4 474 
expression using RT-PCR and western blotting techniques, which may be more 475 
representative of functional responses  476 
 477 
The exact cause for the lower number in resting CAC number and function in older 478 
adults are yet to be fully elucidated. We did observe an inverse relationship in 479 
circulating SDF-1α with age, which may contribute to the lower progenitor cell 480 
number (data not shown), however, it is likely that this is not the single causative 481 
factor. Ageing-associated increases in oxidative stress may play a significant role in 482 
CAC number and function reduction with advancing age (24), via reduced EPC 483 
SIRT1 content (24), reduced CXCR4 gene expression (28), or increased susceptibility 484 
to apoptosis (19). Bone marrow-resident progenitor cells appear unchanged with 485 
advancing age (29), whereas the mobilization of progenitors in older populations are 486 
significantly impaired compared with younger counterparts (17, 47).  However, the 487 
mechanisms for the lower circulating number of progenitor cells and TANG cells are 488 
likely to be very different. TANG cells represent a vasculogenic subpopulation of T-489 
cells (15, 18), and age-associated differences in T-cell populations will differ to that 490 
of bone marrow-derived progenitors. Thymic involution occurs with advancing age, 491 
resulting in a decrease in thymic output of naïve T-cells (36). Studies have shown 492 
distinct T-cell population changes with age, such that the proportion of total T-cells 493 
displaying markers of senescence (e.g. CD28) are elevated in comparison to naïve T-494 
cells (3, 37). In addition, Zehnder et al. (46) found that T-cells lose the expression of 495 
CD31 upon activation, with T-cells differentiating from a naïve to an effector-type T-496 
cell. As we age we encounter many viral antigens, and thus ageing, through the 497 
increased occurrence of these antigen-T-cell encounters, is likely to be associated with 498 
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loss of CD31 expression on effector-type T-cell populations. Therefore, ageing is 499 
potentially promoting the loss of vasculogenic function in the T-cell population. 500 
 501 
To evaluate the effect of CRF on these CACs, we performed multiple level regression 502 
analyses, controlling for age, and when required, confounders (systolic blood 503 
pressure, total cholesterol, LDL-C and SDF-1α). We surprisingly found no association 504 
between CRF on any CAC subset. This was confirmed by no significant difference 505 
found between age-adjusted ?̇?O2max categories when analyzed by one-way ANOVA 506 
for the CAC subsets (data not shown). This is in contrast to previous studies which 507 
have shown the beneficial impact of regular exercise and CRF on resting number 508 
and/or function of EPCs (43). However, our data is in line with several studies which 509 
demonstrate no effect of a regular exercise training program, or increasing levels of 510 
CRF on these cells (39). The differences between studies may be due to the 511 
differences in phenotype of CAC quantified. This is indeed the first study to evaluate 512 
the influence of CRF independent of age on CD34
+
CD45
dim
VEGFR2
+
 population of 513 
EPCs, reported to have endothelial differentiation properties (7), whereas the 514 
CD45
bright
 population do not (7) and are reported to exert beneficial effects on the 515 
endothelium by secreting proangiogenic growth factors and cytokines (16). Therefore, 516 
our study is specifically measuring precursor endothelial cells. 517 
 518 
This is the first study to investigate the influence of CRF, independent of age, on 519 
circulating TANG cells. Previous T-cell studies have reported significant impact of 520 
CRF on T-cell populations, independent of age, reporting an inverse relationship 521 
between proportion of cytotoxic and senescent T-cells with increasing ?̇?O2max (37). 522 
It was expected that since CD31 expression may be lost on effector-memory 523 
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phenotypes, that we would observe similar findings, with increased levels of CD31
+
 524 
T-cells with increasing levels of ?̇?O2max, independent of age. However, no such 525 
effect was observed. Further studies are required to quantify CD31 expression on both 526 
naïve and effector-memory T-cell phenotypes, which may partly explain the effects of 527 
advancing age and potential CRF influences on these vasculogenic T-cells. From our 528 
data we cannot discount that CRF may impact on functional capacities of these cells, 529 
and so, further studies along these lines are required also.  530 
 531 
Acute exercise has been consistently shown to acutely increase circulating progenitor 532 
cells in healthy and diseased populations (33, 40), as well as some functional 533 
improvements in the post-exercise recovery period (41). We have also recently shown 534 
that TANG cells are also redistributed into the circulation immediately post-exercise in 535 
trained men (32). Since advancing age is associated with lower number of basal levels 536 
of CACs, we sought to investigate whether age was also characterized by an exercise-537 
induced impairment in the mobilization of these cells. Our results show that older 538 
individuals display an attenuated circulating progenitor cell increase in response to an 539 
exercise stressor. This response was specifically for CD34
+
CD45
dim
 haematopoietic 540 
progenitors, and CD34
+
CD45
dim
VEGFR2
+
 EPC (p=0.076) and not for CXCR4-541 
expressing progenitors, despite some differences in absolute cell changes. Previously, 542 
we (33) and others (40) have demonstrated that a single bout of exercise is successful 543 
in increasing the number of progenitor cells in peripheral blood, and some have also 544 
demonstrated that this response is attenuated in diseased populations, such as heart 545 
failure (40) and type 2 diabetes mellitus (23). Thijssen et al. (39) were the first to 546 
demonstrate that there were differences in the haematopoietic progenitor cell response 547 
to a single bout of exercise between young and older men which our study supports. 548 
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However, they did not observe such changes with EPCs, and so this is the first study 549 
to demonstrate age-related changes in exercise-induced circulating EPC levels. These 550 
changes could not be explained by differences in circulating chemoattractants such as 551 
VEGF, SDF-1α, or G-CSF as there were no age x exercise interactions, despite an 552 
association between circulating changes in CD34
+
CD45
dim
 cells and SDF-1α only 553 
being present in young individuals.  SDF-1α (31) and G-CSF (30) are known to 554 
stimulate the release of progenitor cells from the bone marrow into the circulation, 555 
and increases in VEGF with acute exercise accompanies increases in circulating EPCs 556 
(33). We did observe significant changes in VEGF with exercise in both groups, but 557 
the change in circulating VEGF did not correlate with changes in either progenitor 558 
cell population. Differences in these acute exercise-induced progenitor cell changes 559 
may be attributable to other known chemoattractants, such as stem cell factor (SCF) 560 
(26), which we did not quantify in this study. Therefore future studies should quantify 561 
a host of known chemoattractants to determine what the factors are that may explain 562 
the age-associated differences in progenitor cell mobilization with acute exercise. 563 
Additionally, some data suggest ageing is linked with reduced bone marrow resident 564 
progenitors (9) therefore a reduced pool from which to mobilize these cells from in 565 
response an acute stressors. 566 
 567 
Our results also show that older adults display a blunted movement of TANG cells into 568 
the blood in response to an acute exercise stressor compared to younger counterparts. 569 
We did observe main effects of exercise for most of our TANG subsets, but 570 
interestingly, the impaired response with advancing age was specific for total TANG 571 
cells, and CD8
+
CXCR4
+
 TANG cells. Acute exercise stimulating an increase in 572 
circulating numbers of these cells have also been reported by our lab previously (32), 573 
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as well as others reporting significant increases in circulating T-cell subsets with a 574 
single bout of moderate and intense exercise (3, 27). The age-related attenuation of 575 
this response, in addition to lower basal levels may partly explain the increased risk of 576 
vascular dysfunction in ageing populations observed elsewhere (4). Other studies 577 
have demonstrated different exercise-induced T-cell changes in older vs. younger 578 
counterparts (3, 27) with greater absolute T-cells entering circulating in response to 579 
exercise in younger individuals in a variety of subsets, namely γδ T-cells (27), and 580 
CD8
+
 naïve subsets (3). We observed greater responsiveness of CD3
+
CD31
+
 and 581 
CD8
+
CXCR4
+
 TANG cells in younger compared to older adults in response to the 30-582 
minute exercise bout. It is unknown the differentiation status of these cells, but these 583 
cells may be naïve or low differentiated cells and may partly explain this response. 584 
The full differentiated status of TANG cells needs to be quantified in order to 585 
investigate this. The impaired response of CXCR4
+
 TANG cells may be of clinical 586 
importance, as these cells possess high migratory capacity to ischaemic tissue. 587 
Previous studies have found that it may be that age-associated impairment in CAC 588 
mobilization/migration is due to altered intracellular signalling of the SDF-589 
1:CXCR4:JAK-2 pathway (43, 44). This has yet to be investigated in T-cells, and thus 590 
is an area of future research. 591 
 592 
Summary 593 
 594 
Older men display reduced number of CACs, as well as an impaired ability to 595 
mobilize and increase circulating number of these cells in response to an acute 596 
exercise stressor. This may partly contribute to age-associated decline in endothelial 597 
function and thus an increased CVD risk. Future studies are required to augment the 598 
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acute exercise response in older men via manipulating the exercise stressor, or via 599 
dietary interventions designed to do as such. 600 
 601 
Limitations 602 
 603 
For study 1, we were limited to the use of a submaximal exercise test to estimate CRF 604 
in 107 individuals aged 18-75yrs. We were able to perform pilot studies prior to study 605 
1 which determined that the YMCA submaximal exercise test was reliable for our 606 
population cohort. Other published studies support this for our age group (2, 13). 607 
Additionally, we would have liked to include functional measures of CACs in our 608 
cohorts which would add significantly to the strength of this study and is a line of 609 
future work. 610 
 611 
This study reflects the changes in CACs with exercise and in different age groups in 612 
men, and so care must be taken to extrapolate these findings to women. There are 613 
some data to suggest that women display higher levels of circulating EPCs compared 614 
to men, potentially due to estrogen availability (10), and that exercise-induced 615 
changes in CAC subsets are affected by the phase of the menstrual cycle (35). Yet 616 
more work is to be done to determine the influence of age and menopause on these 617 
cellular populations. 618 
 619 
CAC subsets expressing CXCR4 displayed large inter-individual variability, and thus 620 
study 2 may be underpowered to fully explain any age-related exercise-induced 621 
response of these cells, and thus further studies should be performed to elucidate the 622 
influence of age on exercise-induced changes in these CAC subsets. 623 
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Figures 805 
 806 
Figure 1. Gating strategies for flow cytometric quantification of CACs. 1A-1E 807 
displays gating strategy for EPC quantification, firstly identification of CD45
+
 808 
PBMCs (1A), subsequent detection of CD34 population vs. side-scatter (1B), 809 
identification of CD45
dim
 population (1C) and VEGFR2 (1D) to quantify 810 
CD34
+
CD45
dim
VEGFR2
+
 EPCs. Finally, CD34
+
 progenitors and EPCs were gated for 811 
expression of CXCR4 (1E). 1F-1K identifies TANG gating strategy, with identification 812 
of lymphocytic gate (1F), gating on CD3
+
 T-cells (1G), and co-expression of CD31 813 
(1H). TANG cells were further gated for subset gating of CD4 (1I) and CD8 (1J), and 814 
finally expression of CXCR4 (1K). 815 
 816 
Figure 2. Age group differences in CAC subpopulations. 2A- Age groups and CD34
+ 
817 
progenitor cell subsets. 2B- Age groups and TANG cell subsets. *p<0.05 vs. 18-30yrs 818 
group. Values shown are mean ± SEM. 819 
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 820 
Figure 3. Circulating progenitor cell changes in response to acute moderate exercise 821 
in young and older healthy men. 3A- CD34
+
CD45
dim
 progenitor cells; 3B - CXCR4-822 
expressing CD34
+
 progenitor cell changes; 3C - EPC changes; 3D- CXCR4-823 
expressing EPC changes.  *p<0.05 main effect of exercise, δ p<0.05 exercise x age 824 
interaction. Values shown are mean ± SEM. 825 
 826 
Figure 4. Circulating TANG cell changes in response to acute moderate exercise in 827 
young and older healthy men. 4A - CD3
+
CD31
+
 T-cell changes; 4B- CXCR4-828 
expressing TANG changes; 4C- CD4
+
 TANG changes; 4D- CXCR4-expressing CD4
+
 829 
TANG changes; 4E- CD8
+
 TANG changes; 4F- CXCR4-expressing CD8
+ 
TANG changes. 830 
*p<0.05 main effect of exercise, δ p<0.05 exercise x age interaction. Values shown 831 
are mean ± SEM.  832 
 833 
Figure 5. Circulating CAC mobilizing factors in response to acute moderate exercise 834 
in young and older healthy men. 5A – SDF-1α changes, 5B – VEGF changes, 5C – G-835 
CSF changes, 5D- Cortisol changes. *p<0.05 main effect of exercise, δ p<0.05 836 
exercise x age interaction. Values shown are mean ± SEM.  837 





Table 1. Study 1 Participant Characteristics (n=107). 
 
All 
(n=107) 
18-30 years 
(n=36) 
31-50 years 
(n=42) 
51-75 years 
(n=25) 
p-
value 
Age  
(years) 
39 ± 14 24 ± 3 41 ± 6* 58 ± 5*
#
 0.000 
BMI  
(kg·m
2
) 
25.83 ± 2.60 26.06 ± 2.37 26.05 ± 2.45 25.09 ± 3.12 NS 
SBP  
(mmHg) 
130 ± 15 126 ± 10 129 ± 13 140 ± 19* 0.000 
DBP 
(mmHg) 
78 ± 9 73 ± 8 80 ± 8 84 ± 9* 0.000 
MAP  
(mmHg) 
96 ± 10 90 ± 7 96 ± 9* 103 ± 11* 0.000 
Estimated 
?̇?O2max  
(mL·kg·min
-1
) 
[Range] 
43.60 ± 9.48 
[16.89-66.78] 
44.19 ± 7.99 
[31.55-57.59] 
47.03 ± 9.62 
[26.05-66.78] 
36.70 ± 7.82*
# 
[16.89-52.78] 
0.000 
Values are mean ± Standard Deviation. BMI- Body Mass Index, SBP- Systolic Blood 
Pressure, DBP- Diastolic Blood Pressure, MAP- Mean Arterial Pressure. * p<0.05 vs. 18-30 
years,
 # 
p<0.05 vs. 31-50 years. NS- not significant. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Values shown are mean ± standard deviation. *p<0.05, **p<0.005 
 
Table 
2. 
Acute 
Exerci
se 
Study 
Partici
pant 
Chara
cterist
ics 
and 
Acute Exercise Data (n=17). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Values shown are mean ± standard deviation. *p<0.05, **p<0.005 
 Young (n=8) Older (n=9) p-value 
Age (years) 23 ± 2 65 ± 3 0.000** 
Systolic Blood Pressure (mmHg) 126 ± 13 124 ± 13 0.771 
Diastolic Blood Pressure (mmHg) 65 ± 8 74 ± 6 0.012* 
Body Mass Index (kg·m
2
) 25.5 ± 3.5 26.1 ± 3.5 0.755 
Resting Heart Rate (bpm) 66 ± 12 57 ± 6 0.057 
?̇?O2max (ml·kg·min
-1
) 48.8 ± 8.2 35.1 ± 6.7 0.002** 
Workload at ?̇?O2max (Watts) 325 ± 38 219 ± 27 0.000** 
Trial Data    
Workload (Watts) 230 ± 27 156 ± 23 0.000** 
Average Heart Rate (bpm) 155 ± 14 127 ± 15 0.001** 
% of Maximal Heart Rate 79 ± 7 82 ± 10 0.461 
 
